HOME > VC DEALS > Expedition Therapeutics
Deal IconDeal

Expedition Therapeutics

Expedition Therapeutics raises $115M Series B

Expedition Therapeutics, a San Francisco-based COPD therapeutics developer, raised $115 million in a Series B fundraising round led by General Atlantic with participation from RA Capital and Vivo Capital.

More on VCNewsDaily →


Similar Health deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs